Skip to main content
  • Malays, Indians with Type 2 diabetes more likely to suffer strokes, heart attacks: Study
    SINGAPORE: In a decade-long diabetes study, researchers from Khoo Teck Puat Hospital (KTPH) found that among those with Type 2 Diabetes Mellitus (T2DM), Malays and Indians are at higher risk of cardiovascular diseases compared to Chinese patients. Malay patients had two times higher risk while Indians had 1.7 times higher risk of diseases such as heart attacks and strokes, compared to Chinese patients with T2DM, according to findings of a study released by the healthcare cluster that manages…
  • FDA Approves Generic Celebrex
    In June 2014, the U.S. Food and Drug Administration (FDA) approved two generic versions of celecoxib (Celebrex). Developed by Pfizer, celexocib is used to treat rheumatoid arthritis, osteoarthritis, as well as other conditions. Approval was granted to Mylan Pharmaceuticals, Inc. to market 50 mg celecoxib capsules, while Teva Pharmaceutical Industries received approval to market the drug in the following doses: 50 mg, 100 mg, 200 mg, and 400 mg, according to a bulletin from the FDA. Teva was…
  • Man walks again after ground breaking cell transplant - Pre-clinical trial
    On a warm summer's day in Wroclaw, Poland, Darek Fidyka walked across a bridge, using only a frame for support. This had been his dream for four years, after he was paralysed in a knife attack. Now, after a transplant of cells taken from his nasal cavity, it had become reality. He is the world's first patient to receive the groundbreaking treatment. Behind those few steps lay the extraordinary efforts of a group of scientists, surgeons and fundraisers in Britain and Poland. Dr Tabakow…
  • FDA Approval For Two-In-One Diabetes Pill XIGDUO™ XR
    U.S. Food and Drug Administration has approved once-daily XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes. It is already approved in Australia XIGDUO XR combines two anti-hyperglycemic agents with complementary mechanisms of action, dapagliflozin (trade name in the U.S. FARXIGA™), an inhibitor of sodium-glucose cotransporter 2 (SGLT2), and metformin hydrochloride (HCl) extended-release, a biguanide, in a once-daily oral…
  • India launches diagnostic kit that detects celiac disease in 20 minutes
    Celiac disease is a relatively new health disorder in India and experts claim that only a handful of patients are diagnosed. Majority of patients are still undiagnosed. In its press statement, Department of Biotechnology (DoB) said almost one per cent of north Indian population is suffering from the disease in which the inner lining of the small intestine (where food is digested and absorbed) gets damaged and food is not absorbed properly. Non-absorption of food leads to weight loss, prolonged…
  • Giant leap in Type 1 Diabetes treatment
    Harvard stem cell researchers today announced that they have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a condition that affects an estimated 3 million Americans at a cost of about $15 billion annually. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing…
  • Old photos helping trigger memories in people with dementia
    Pictures taken by a little-known photographer between the 1930s and 1960s have found a new use helping to trigger memories and reminiscences among people with dementia. "In the dementia care world reminiscence is up there as one of the leading groups of therapeutic approaches," explains Prof Bob Woods, an expert in the clinical psychology of older people at Bangor University. "Essentially it's a good way of facilitating communication, and so it helps people to feel more socially integrated and…
  • Parents deny girls cancer treatment, say doctors
    Cancer Institute chairperson Dr V Shanta expressed concern over underreporting of cancer among children, especially in rural areas. Advances in oncology over the past six decades have ensured that up to 75 % of all paediatric cancers can be cured. While it is possible to treat all pediatric cases in the country, there is a need to increase affordability and accessibility for the same," she said. http://timesofindia.indiatimes.com/City/Chennai/Parents-deny-girls-cancer-treatment-say-doctors…
  • Simple lifestyle interventions during pregnancy can prevent children from becoming obese
    In a study that followed more than 2,200 obese women during pregnancy, scientists found that some simple interventions can help prevent high birth weights in newborns. This is important because previous studies have shown that infants with a high birth weight have a greater risk of becoming obese as children or adults. Professor Jodie Dodd summarizes the results: "Infants born to women who received lifestyle advice were 18% less likely to have a high birth weight compared to infants born to…